University of Texas's MD Anderson Cancer: Engineered NK Cells Can Eliminate Glioblastoma Stem Cells
June 18, 2021
June 18, 2021
HOUSTON, Texas, June 18 (TNSJou) -- The University of Texas's MD Anderson Cancer Center issued the following news release on June 17, 2021:
Preclinical research from The University of Texas MD Anderson Cancer Center finds that although glioblastoma stem cells (GSCs) can be targeted by natural killer (NK) cells, they are able to evade immune attack by releasing the TFG- Beta signaling protein, which blocks NK cell activity. Deleting the TFG-Beta receptor in NK cells, however, re . . .
Preclinical research from The University of Texas MD Anderson Cancer Center finds that although glioblastoma stem cells (GSCs) can be targeted by natural killer (NK) cells, they are able to evade immune attack by releasing the TFG- Beta signaling protein, which blocks NK cell activity. Deleting the TFG-Beta receptor in NK cells, however, re . . .